Evidence map›Paper›PMID 39281409›Full record

ArticleFrontiers in neurology2024

Multimodal therapy and use of adjunctive therapies to BoNT-A in spasticity management: defining terminology to help enhance spasticity treatment.

Rajiv Reebye, Luis Jorge Jacinto, Alexander Balbert, Bo Biering-Sørensen, Stefano Carda, Nathalie Draulans, Franco Molteni, Michael W O'Dell, Alessandro Picelli, Andrea Santamato and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07513714 (Efficacy of Functional Electrical Stimulation), which is not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07513714 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Efficacy of Functional Electrical Stimulation (FES) Combined With Task- Oriented Training on Upper Limb Recovery in Post-Stroke Patients With Spastic Hemiparesis: A Randomized Controlled Trial

TypeinterventionalSponsorUniversity of FoggiaRan2026 to 2026Enrolled40ConditionsStroke, Post-Stroke Spasticity, Post-Stroke HemiparesisArmsFunctional Electrical Stimulation (FES), Conventional Rehabilitation
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Exploring the Impact of Muscle Vibration Therapy in Neurologic Rehabilitation: A Systematic Review.Archives of rehabilitation research and clinical translation · 2025
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rajiv Reebye *Division of Physical Medicine and Rehabilitation, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Luis Jorge Jacinto *Adult Rehabilitation Service, Alcoitão Rehabilitation Medicine Center, Estoril, Portugal.
Alexander BalbertDepartment of Adaptive Physical Training, Ural University of Physical Education, Sverdlovsk Regional Hospital for War Veterans, Yekaterinburg, Russia.
Bo Biering-SørensenNeurological Department, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Stefano CardaNeuropsychology and Neurorehabilitation, Lausanne University Hospital, Lausanne, Switzerland.
Nathalie DraulansDepartment of Rehabilitation, Libra Rehabilitation and Audiology, Eindhoven, Netherlands.
Franco MolteniVilla Beretta Rehabilitation Center, Valduce Hospital, Costa Masnaga, Italy.
Michael W O'DellClinical Rehabilitation Medicine, Weill Cornell Medicine and Neuro Rehabilitation Consultants, New York, NY, United States.
Alessandro PicelliNeuromotor and Cognitive Research Center, Section of Physical and Rehabilitation Medicine, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Andrea SantamatoUnit of Spasticity and Movement Disorders, Division of Physical Medicine and Rehabilitation, University Hospital of Foggia, Foggia, Italy.
Monica Verduzco-GutierrezDepartment of Rehabilitation Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
Heather WalkerPhysical Medicine and Rehabilitation, Ralph H. Johnson VA Medical Center, Charleston, SC, United States.
Joerg WisselNeurology and Psychosomatic at Wittenbergplatz, Berlin and University Potsdam, Potsdam, Germany.
Gerard E Francisco *Department of Physical Medicine and Rehabilitation, The University of Texas Health Science Center McGovern Medical School, Houston, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spasticity management should be provided within the context of a comprehensive person-centered rehabilitation program. Furthermore, active goal setting for specific spasticity interventions is also important, with a well-established "more is better" approach. It is critical to consider adjunctive therapy and multimodal approaches if patients are not attaining their treatment goals. Often used interchangeably, there may be confusion between the terms adjunctive and multimodal therapy. Yet it is imperative to understand the differences between these approaches to achieve treatment goals in spasticity management. Addition of a secondary pharmacologic or non-pharmacologic treatment to optimize the efficacy of the initial modality, such as adding electrical stimulation or casting to BoNT-A, is considered an adjunctive therapy. Adjunctive therapy is time-specific and requires the added therapy be initiated within a specific period to enhance the primary treatment; usually within 2 weeks. Multimodal therapy is an integrated, patient-centric program of pharmacologic and non-pharmacologic strategies utilized in a concurrent/integrated or sequential manner to enhance the overall treatment effect across a variety of spasticity-associated impairments (e.g., neural and non-neural components). Moreover, within a multimodal approach, adjunctive therapy can be used to help enhance the treatment effect of one specific modality. The objectives of this paper are to clarify the differences between adjunctive and multimodal therapies, provide a brief evidence-based review of such approaches, and highlight clinical insights on selecting multimodal and adjunctive therapies in spasticity management.

Indexed as

augmentationbotulinum neurotoxincombined modalitymuscle spasticitymuscular paresisrecovery of function

Identifiers

PMID39281409
PMCPMC11392737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.